vTv Therapeutics Inc (VTVT): Perelman has years ago signed an agreeme...

Reply Private New

Replies (1) Next 10 Prev Next

Investor2014

Send PM Follow Ignore

Followers	62
Posts	24648
Boards Moderated	0
Alias Born	11/23/2016

Investor2014

Re: Tom turtles post# 570

Thursday, 10/21/2021 3:53:25 AM

Thursday, October 21, 2021 3:53:25 AM

Perelman has years ago signed an agreement with vTv funding them on demand by buying the shares they issue.

Insider buying on that basis doesn’t tell you very much other than perhaps Perelman may be a sucker holding a big bag.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent VTVT News

Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2024 08:29:55 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 09/23/2024 08:28:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:27:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:20:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 08:17:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:22:16 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:42:02 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:38:28 PM
CANTEX PHARMACEUTICALS ANNOUNCES FOUR ABSTRACTS TO BE PRESENTED FEATURING AZELIRAGON AT 2024 ASCO ANNUAL MEETING • PR Newswire (US) • 05/28/2024 12:00:00 PM
vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/09/2024 08:51:46 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:32:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:28:15 PM
CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT • PR Newswire (US) • 03/19/2024 12:30:00 PM
vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/13/2024 12:00:00 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:47:37 PM
Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 03/06/2024 12:52:29 AM
Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 01:04:31 PM
vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes • GlobeNewswire Inc. • 03/04/2024 01:00:00 PM
vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference • GlobeNewswire Inc. • 03/01/2024 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 02:26:55 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/28/2024 02:14:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 01:08:30 PM
vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund • GlobeNewswire Inc. • 02/28/2024 01:00:00 PM

More VTVT News

InvestorsHub NewsWire

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM

Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM

Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM

Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM

CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM

Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover